Results of a Phase 2 Clinical Trial at 48 Weeks (AI424-007): A Dose-Ranging, Safety, and Efficacy Comparative Trial of Atazanavir at Three Doses in Combination with Didanosine and Stavudine in Antiretroviral-Naive Subjects

2003 ◽  
Vol 32 (1) ◽  
pp. 18-29 ◽  
Author(s):  
Ian Sanne ◽  
Peter Piliero ◽  
Kathleen Squires ◽  
Alexandra Thiry ◽  
Steven Schnittman
Keyword(s):  
Clinical Trial ◽  
Comparative Trial ◽  
Phase 2 ◽  
Safety And Efficacy ◽  
Phase 2 Clinical Trial ◽  
Dose Ranging

scholarly journals Safety and efficacy of MIM D3 ophthalmic solutions in a randomized placebo controlled Phase 2 clinical trial in patients with dry eye

2013 ◽  
pp. 1275 ◽  
Author(s):  
Karen Meerovitch ◽  
Gail Torkildsen ◽  
John Lonsdale ◽  
Heidi Goldfarb ◽  
Teresa Lama ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Dry Eye ◽  
Phase 2 ◽  
Safety And Efficacy ◽  
Phase 2 Clinical Trial ◽  
Ophthalmic Solutions

Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial

2019 ◽  
Vol 3 ◽  
pp. S9
Author(s):  
Zoe Draelos ◽  
Fran Cook-Bolden ◽  
Lawrence Green ◽  
Eric Guenin ◽  
Gina Martin ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Patient Reported Outcomes ◽  
Phase 2 ◽  
Patient Reported ◽  
Phase 2 Clinical Trial

Abstract not available.

Sign in / Sign up

Export Citation Format

Share Document